BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2024 12:23:38 PM | Browse: 98 | Download: 508
 |
Received |
|
2024-07-19 10:02 |
|
Peer-Review Started |
|
2024-07-19 10:02 |
|
First Decision by Editorial Office Director |
|
2024-09-17 00:39 |
|
Return for Revision |
|
2024-09-17 00:39 |
|
Revised |
|
2024-10-09 13:53 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-10-18 01:29 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-10-18 09:10 |
|
Articles in Press |
|
2024-10-18 09:10 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-10-30 14:52 |
|
Publish the Manuscript Online |
|
2024-11-12 12:23 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Advancing hepatocellular carcinoma treatment with hepatic arterial infusion chemotherapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Eda Caliskan Yildirim and Yakup Ergun |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yakup Ergun, MD, Associate Professor, Department of Medical Oncology, Antalya City Hospital, Göçerler, 5379th Street, Antalya 07080, Türkiye. dr.yakupergun@gmail.com |
| Key Words |
Hepatocellular carcinoma; Hepatic arterial infusion chemotherapy; Tyrosine kinase inhibitors; Immunotherapy; Survival |
| Core Tip |
Hepatic arterial infusion chemotherapy (HAIC) is shown to be a highly effective and safer treatment for advanced hepatocellular carcinoma. Despite its success in Asia, HAIC is underutilized in western countries. Further research and clinical trials in diverse populations are essential to validate HAIC’s benefits and integrate it into global oncology practices. |
| Publish Date |
2024-11-12 12:23 |
| Citation |
Caliskan Yildirim E, Ergun Y. Advancing hepatocellular carcinoma treatment with hepatic arterial infusion chemotherapy. World J Gastrointest Oncol 2024; 16(12): 4757-4761 |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i12/4757.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i12.4757 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
